¼¼°èÀÇ ¼öÀÇ Á¾¾çÇÐ ½ÃÀå
Veterinary Oncology
»óǰÄÚµå : 1594925
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2024³â 11¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 93 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,464,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 25,393,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼öÀÇ Á¾¾çÇÐ ¼¼°è ½ÃÀåÀº 2030³â±îÁö 7¾ï 2,780¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î Àü¸Á

2023³â 3¾ï 5,820¸¸ ´Þ·¯·Î ÃßÁ¤µÇ´Â ¼öÀÇ Á¾¾çÇÐ ¼¼°è ½ÃÀåÀº 2023-2030³âÀÇ ºÐ¼® ±â°£ µ¿¾È ¿¬Æò±Õ 10.7% ¼ºÀåÇÏ¿© 2030³â¿¡´Â 7¾ï 2,780¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. º» º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ È­Çпä¹ýÀº CAGR 11.8%¸¦ ±â·ÏÇÏ¿© ºÐ¼® ±â°£ Á¾·á ½ÃÁ¡¿¡ 2¾ï 4,600¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¹æ»ç¼± ºÐ¾ßÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ µ¿¾È CAGR 9.4%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 9,340¸¸ ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 14.0%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»ó

¹Ì±¹ ¼öÀÇ Á¾¾çÇÐ ½ÃÀåÀº 2023³â 9,340¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦ ´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö ½ÃÀå ±Ô¸ð°¡ 1¾ï 6,800¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2023-2030³âÀÇ ºÐ¼® ±â°£ µ¿¾È 14.0%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ Àü¸ÁÀÔ´Ï´Ù. ´Ù¸¥ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ª ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ µ¿¾È °¢°¢ 7.2%¿Í 8.8%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ Àü¸ÁÀÔ´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ ¾à 8.3%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ Àü¸ÁÀÔ´Ï´Ù.

¼¼°è ¼öÀÇ Á¾¾çÇÐ ½ÃÀå - ÁÖ¿ä µ¿Çâ ¹× ÃËÁø¿äÀÎ Á¤¸®

¼öÀÇ Á¾¾çÇÐÀ̶õ ¹«¾ùÀ̸ç, ¿Ö µ¿¹°ÀÇ·á¿¡¼­ ¸Å¿ì Áß¿äÇѰ¡?

¼öÀÇ Á¾¾çÇÐÀº µ¿¹°ÀÇ ¾Ï Áø´Ü, Ä¡·á ¹× °ü¸®¿¡ ÃÊÁ¡À» ¸ÂÃá ¼öÀÇÇÐ Àü¹® ºÐ¾ßÀÔ´Ï´Ù. È­Çпä¹ý, ¹æ»ç¼±¿ä¹ý, ¸é¿ª¿ä¹ý, ¼ö¼ú, Ç¥ÀûÄ¡·á µî ´Ù¾çÇÑ Ä¡·á¹ýÀÌ ÀÖÀ¸¸ç, ¹Ý·Áµ¿¹°°ú °¡Ãà, ½ÉÁö¾î À̱¹ÀûÀÎ µ¿¹°ÀÇ ¸²ÇÁÁ¾, ºñ¸¸¼¼Æ÷Á¾, °ñÀ°Á¾, Èæ»öÁ¾ µî ´Ù¾çÇÑ À¯ÇüÀÇ ¾ÏÀ» Ä¡·áÇϱâ À§ÇØ °í¾ÈµÈ Ä¡·á¹ýµéÀÌ ÀÖ½À´Ï´Ù. ¼öÀÇ Á¾¾çÇÐÀº Á¶±â Áø´Ü, °í±Þ Ä¡·á ¿É¼Ç ¹× Áö¼ÓÀûÀÎ Ä¡·á¸¦ ÅëÇØ µ¿¹°ÀÇ ¼ö¸íÀ» ¿¬ÀåÇϰí ÅëÁõÀ» ¿ÏÈ­ÇÏ¸ç ¾Ï È¯ÀÚÀÇ »îÀÇ ÁúÀ» Çâ»ó½ÃŰ´Â °ÍÀ» ¸ñÇ¥·Î ÇÕ´Ï´Ù.

¼öÀÇ Á¾¾çÇÐÀÇ Á߿伺Àº °³¿Í °í¾çÀÌ¿Í °°Àº ¹Ý·Áµ¿¹°»Ó¸¸ ¾Æ´Ï¶ó °¡Ãà°ú ¾ß»ýµ¿¹°¿¡¼­ Áõ°¡ÇÏ´Â ¾Ï À¯º´·ü¿¡ ´ëÀÀÇÏ°í µ¿¹°¿¡°Ô Á¾ÇÕÀûÀÎ ¾Ï Ä¡·á¸¦ Á¦°øÇÒ ¼ö ÀÖ´Â ´É·Â¿¡ ÀÖ½À´Ï´Ù. °Ç°­ °ü¸®, ¿µ¾ç ¹× »ýȰ ȯ°æÀÇ °³¼±À¸·Î ¹Ý·Áµ¿¹°ÀÇ ¼ö¸íÀÌ ±æ¾îÁö¸é¼­ ¾Ï°ú °°Àº ³ëÈ­ °ü·Ã Áúº´ÀÌ Á¡Á¡ ´õ ÈçÇØÁö°í ÀÖ½À´Ï´Ù. ¼öÀÇ Á¾¾çÇÐÀº Àü¹®ÀûÀÎ Áø´Ü µµ±¸, ¸ÂÃãÇü Ä¡·á °èȹ ¹× ¿ÏÈ­ Ä¡·á¸¦ Á¦°øÇÏ¿© ¹Ý·Áµ¿¹° º¸È£ÀÚ°¡ º¹ÀâÇÑ ¾Ï »ç·Ê¸¦ º¸´Ù È¿°úÀûÀ¸·Î °ü¸®ÇÒ ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù. µ¿¹° º¹Áö¿Í º¸È£ÀÚ¿Í µ¿¹° »çÀÌÀÇ Á¤¼­Àû À¯´ë°¨¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó µ¿¹° Á¾¾çÇÐÀº µ¿¹°¿¡ ´ëÇÑ ´õ ³ôÀº ¼öÁØÀÇ ¹è·Á¸¦ Ãß±¸ÇÏ´Â ±¤¹üÀ§ÇÑ Ãß¼¼¿Í ÀÏÄ¡Çϸç Çö´ë ¼öÀÇÇп¡ ÇʼöÀûÀÎ ¿ä¼Ò·Î ÀÚ¸® Àâ°í ÀÖ½À´Ï´Ù.

±â¼úÀÇ ¹ßÀüÀº ¼öÀÇ Á¾¾çÇÐ ½ÃÀåÀ» ¾î¶»°Ô Çü¼ºÇϰí Àִ°¡?

±â¼úÀÇ ¹ßÀüÀº ¼öÀÇ Á¾¾çÇÐÀÇ Áø´Ü, Ä¡·á ¹× ¿ÏÈ­ ´É·ÂÀ» Å©°Ô Çâ»ó½ÃÄÑ ÀÌ ºÐ¾ß Àü¹ÝÀÇ ±â¼ú Çõ½ÅÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ÁÖ¿ä ¹ßÀü Áß Çϳª´Â ÄÄÇ»ÅÍ ´ÜÃþÃÔ¿µ(CT), ÀÚ±â°ø¸í¿µ»ó(MRI), ¾çÀüÀÚ¹æ»ç¼±´ÜÃþÃÔ¿µ(PET), ÃÊÀ½ÆÄ µî ÷´Ü ¿µ»óÁø´Ü ±â¼úÀÇ µîÀåÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ¿µ»óÁø´ÜÀº Á¾¾çÀÇ Å©±â, À§Ä¡, ÁøÇà Á¤µµ¿¡ ´ëÇÑ »ó¼¼ÇÑ Á¤º¸¸¦ Á¦°øÇÏ¿© ¼öÀǻ簡 ¾ÏÀ» Á¤È®ÇÏ°Ô Áø´ÜÇϰí, Ä¡·á °èȹÀ» ¼¼¿ì°í, ¹ÝÀÀÀ» ¸ð´ÏÅ͸µÇÒ ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù. ¶ÇÇÑ, ¿µ»ó À¯µµ »ý°Ë°ú ¼ö¼úÀÇ Á¤È®µµ°¡ Çâ»óµÇ¾î Á¶Á÷ ¼Õ»óÀ» ÃÖ¼ÒÈ­ÇÏ°í ¼º°øÀûÀÎ Á¾¾ç Á¦°Å °¡´É¼ºÀ» ³ôÀ̰í ÀÖ½À´Ï´Ù.

Ç¥ÀûÄ¡·á¿Í ¸é¿ªÄ¡·áÀÇ ¹ßÀüÀº µ¿¹°ÀÇ ¾Ï Ä¡·á¿¡ »õ·Î¿î ´ë¾ÈÀ» Á¦½ÃÇÏ¸ç ¼öÀÇ Á¾¾çÇÐÀ» º¯È­½ÃÄ×½À´Ï´Ù. Ç¥Àû Ä¡·á´Â °Ç°­ÇÑ Á¶Á÷¿¡ ¿µÇâÀ» ¹ÌÄ¡Áö ¾Ê°í ƯÁ¤ ¾Ï¼¼Æ÷¸¦ °ø°ÝÇϵµ·Ï ¼³°èµÈ ¾à¹°À» »ç¿ëÇÏ¿© È¿´ÉÀ» Çâ»ó½ÃŰ°í ºÎÀÛ¿ëÀ» ÁÙÀÔ´Ï´Ù. Ƽ·Î½Å Ű³ª¾ÆÁ¦ ¾ïÁ¦Á¦(TKI)¿Í ´ÜÀÏ Å¬·Ð Ç×ü´Â ƯÈ÷ ºñ¸¸¼¼Æ÷Á¾À̳ª ¸²ÇÁÁ¾°ú °°Àº Áõ»ó¿¡ ´ëÇØ ¼öÀÇ Á¾¾çÇп¡¼­ Á¡Á¡ ´õ ¸¹ÀÌ »ç¿ëµÇ°í Àִ ǥÀû Ä¡·áÀÇ ÇÑ ¿¹ÀÔ´Ï´Ù. µ¿¹°ÀÇ ¸é¿ªÃ¼°è¸¦ ÀÚ±ØÇÏ¿© ¾Ï¼¼Æ÷¸¦ ÀνÄÇÏ°í ÆÄ±«Çϵµ·Ï ÇÏ´Â ¸é¿ª¿ä¹ýµµ ´Ù¾çÇÑ À¯ÇüÀÇ Á¾¾ç¿¡ ´ëÇÑ À¯¸ÁÇÑ Ä¡·á¹ýÀ¸·Î ¶°¿À¸£°í ÀÖ½À´Ï´Ù. °³ Èæ»öÁ¾ ¹é½Å°ú °°Àº ¹é½ÅÀº °ø°Ý¼ºÀÌ ³ôÀº ¾Ï Ä¡·á¿¡ ¸é¿ª ¿ä¹ýÀ» »ç¿ëÇÏ´Â µ¥ ÀÖ¾î Å« µ¹ÆÄ±¸°¡ µÉ ¼ö ÀÖ½À´Ï´Ù.

À¯ÀüÀÚ °Ë»ç ¹× ºÐÀÚÁø´ÜÀ» Æ÷ÇÔÇÑ Á¤¹ÐÀÇ·áÀÇ µµÀÔÀ¸·Î ¼öÀÇ»ç´Â º¸´Ù ¸ÂÃãÈ­µÈ Ä¡·á °èȹÀ» ¼ö¸³ÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. Á¾¾çÀÇ À¯ÀüÀû ±¸¼ºÀ» ºÐ¼®ÇÔÀ¸·Î½á ¼öÀÇ ¾Ï Àü¹®ÀÇ´Â Ä¡·á °áÁ¤ÀÇ ÁöħÀÌ µÇ´Â ƯÁ¤ µ¹¿¬º¯À̸¦ ã¾Æ³»¾î Ä¡·á È¿°ú¸¦ ³ôÀÌ°í »ýÁ¸À²À» ³ôÀÏ ¼ö ÀÖ½À´Ï´Ù. ¹æ»ç¼± Ä¡·áÀÇ ÅëÇÕµµ ¹ßÀüÇϰí ÀÖÀ¸¸ç, Á¤À§Àû ¹æ»ç¼± Ä¡·á(SRT)¿Í °­µµÁ¶Àý ¹æ»ç¼± Ä¡·á(IMRT)°¡ »ç¿ëµÇ¾î ÁÖº¯ °Ç°­ÇÑ Á¶Á÷¿¡ ´ëÇÑ ¼Õ»óÀ» ÃÖ¼ÒÈ­ÇÏ´Â °í¼±·® Ç¥Àû Ä¡·á¸¦ Á¦°øÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú Çõ½ÅÀº ¼öÀÇ Á¾¾çÇп¡¼­ »ç¿ëÇÒ ¼ö ÀÖ´Â Ä¡·á ¿É¼ÇÀ» ³ÐÈú »Ó¸¸ ¾Æ´Ï¶ó, µ¿¹°¿¡°Ô º¸´Ù °³ÀÎÈ­µÇ°í Á¤È®Çϸç È¿°úÀûÀÎ ¾Ï Ä¡·á¸¦ Á¦°øÇϱâ À§ÇÑ º¸´Ù ±¤¹üÀ§ÇÑ Ãß¼¼¿Íµµ ÀÏÄ¡ÇÕ´Ï´Ù.

´Ù¾çÇÑ µ¿¹° Á¾¿¡ ´ëÇÑ ¼öÀÇ Á¾¾çÇÐÀÇ »õ·Î¿î Àû¿ë »ç·Ê´Â ¹«¾ùÀΰ¡?

¼öÀÇ Á¾¾çÇÐÀº ¹Ý·Áµ¿¹°°ú ºñ¹Ý·Áµ¿¹° ¸ðµÎ¿¡¼­ Àü¹®ÀûÀÎ ¾Ï Ä¡·áÀÇ Çʿ伺À¸·Î ÀÎÇØ ´Ù¾çÇÑ µ¿¹°Á¾¿¡¼­ ±× ¿ëµµ°¡ È®´ëµÇ°í ÀÖ½À´Ï´Ù. °³¿Í °í¾çÀÌ¿Í °°Àº ¹Ý·Áµ¿¹°¿¡¼­´Â ¸²ÇÁÁ¾, ºñ¸¸¼¼Æ÷Á¾, °ñÀ°Á¾, À¯¼±Á¾¾ç µî¿¡ Á¾¾çÇÐ Ä¡·á°¡ ÀϹÝÀûÀ¸·Î »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. È­Çпä¹ýÀº ¿©ÀüÈ÷ ³Î¸® »ç¿ëµÇ´Â Ä¡·á¹ýÀ̸ç, ¾ÏÀÇ À¯Çü°ú º´±â¿¡ µû¶ó ¼ö¼úÀ̳ª ¹æ»ç¼± Ä¡·á¿Í º´ÇàÇÏ´Â °æ¿ì°¡ ¸¹½À´Ï´Ù. ¼Òµ¿¼ö󸮿¡¼­´Â º¹°­°æ Á¾¾ç ÀýÁ¦¼ú°ú °°Àº ÃÖ¼Ò Ä§½ÀÀû ¼ö¼ú ±â¹ýÀÇ »ç¿ëµµ Áõ°¡Çϰí ÀÖ¾î ȸº¹ ±â°£ÀÌ ´ÜÃàµÇ°í Ä¡·á ¼ºÀûµµ Çâ»óµÇ°í ÀÖ½À´Ï´Ù.

¸»°ú °¡ÃàÀ» Æ÷ÇÔÇÑ ´ëµ¿¹°¿¡¼­´Â ÆíÆò»óÇǾÏ, À¯À°Á¾, ¸²ÇÁÁ¾ µîÀÇ Áúº´ °ü¸®¿¡ ¼öÀÇ Á¾¾çÇÐÀÌ Àû¿ëµË´Ï´Ù. ÇØºÎÇÐÀû, »ý¸®Àû Â÷ÀÌ¿¡ µû¶ó Ä¡·á¹ýÀº ´Ù¸£Áö¸¸, ¹æ»ç¼±À̳ª ³Ãµ¿ ¼ö¼ú°ú °°Àº ÷´Ü Ä¡·á¹ýÀÌ ¸»ÀÇ Á¾¾ç Ä¡·á¿¡ äÅÃµÇ¾î »ýÁ¸À²°ú »îÀÇ ÁúÀ» Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù. ´ëµ¿¹°¿¡ ¸Â°Ô Á¶Á¤µÈ È­ÇÐ ¿ä¹ý ÇÁ·ÎÅäÄÝÀº ÁöÁö ¿ä¹ý°ú °áÇÕµÇ¾î °¡Ãà, ƯÈ÷ ±ÍÁßÇÑ ¹ø½Ä µ¿¹°¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ƯÁ¤ À¯ÇüÀÇ ¾ÏÀ» °ü¸®Çϱâ À§ÇÑ ¼öÀÇ Á¾¾çÇÐ °üÇàÀÇ ÀϺÎÀ̱⵵ ÇÕ´Ï´Ù.

µ¿¹°¿ø µ¿¹°, Á¶·ù, ÆÄÃæ·ù ¹× ±âŸ µ¿¹°¿ø µ¿¹°°ú ¾ß»ýµ¿¹°¿¡¼­ ¼öÀÇ Á¾¾çÇÐÀº µ¿¹°¿ø µ¿¹°, Á¶·ù, ÆÄÃæ·ù ¹× Àΰ£ÀÌ °ü¸®ÇÏ´Â ´Ù¸¥ Á¾ÀÇ ¾ÏÀ» °ü¸®ÇÏ´Â µ¥ ÇʼöÀûÀÎ ºÐ¾ßÀÔ´Ï´Ù. ÀÌµé µ¿¹°Àº ÇØºÎÇÐÀû ±¸Á¶, Çൿ ¹× ¸é¿ª ¹ÝÀÀÀÇ Â÷ÀÌ·Î ÀÎÇØ ¾Ï Ä¡·á¿¡ ÀÖ¾î µ¶Æ¯ÇÑ °úÁ¦¸¦ °¡Áö°í ÀÖÀ¸¸ç, Àü¹®ÀûÀÎ Áø´Ü ¹× Ä¡·á Á¢±Ù¹ýÀÌ ÇÊ¿äÇÕ´Ï´Ù. ¿¹¸¦ µé¾î, Àü±âÈ­Çпä¹ý(È­Çпä¹ý°ú Àü±â ÆÞ½ºÀÇ Á¶ÇÕ)°ú °°Àº Çõ½ÅÀûÀÎ Á¢±Ù¹ýÀº ¼ÒÇü Æ÷À¯·ù¿Í À̱¹ÀûÀÎ ¹Ý·Áµ¿¹°ÀÇ Á¾¾ç Ä¡·á¿¡ »ç¿ëµÇ¾î È¿°úÀûÀ̰í ÃÖ¼Ò Ä§½ÀÀûÀÎ Ä¡·á ¿É¼ÇÀ» Á¦°øÇÕ´Ï´Ù. ´Ù¾çÇÑ µ¿¹°Á¾¿¡¼­ ¼öÀÇ Á¾¾çÇÐÀÇ Àû¿ëÀÌ È®´ëµÇ°í ÀÖ´Â °ÍÀº µ¿¹° °Ç°­°ü¸®ÀÇ ¹ßÀü°ú ¾Ï µ¿¹°ÀÇ ¿¹ÈÄ °³¼±¿¡ ÀÖ¾î ¼öÀÇ Á¾¾çÇÐÀÌ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖÀ½À» ÀÔÁõÇÕ´Ï´Ù.

¼öÀÇ Á¾¾çÇÐ ½ÃÀåÀÇ ¼ºÀå ÃËÁø¿äÀÎÀº ¹«¾ùÀΰ¡?

¼öÀÇ Á¾¾çÇÐ ½ÃÀåÀÇ ¼ºÀåÀº ¹Ý·Áµ¿¹° »çÀ° Áõ°¡, ¹Ý·Áµ¿¹° °Ç°­¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡, ¾Ï Ä¡·á ±â¼úÀÇ ¹ßÀü µî ¿©·¯ °¡Áö ¿äÀο¡ ±âÀÎÇÕ´Ï´Ù. ÁÖ¿ä ¼ºÀå ¿äÀÎ Áß Çϳª´Â ¹Ý·Áµ¿¹°À» °¡Á·ÀÇ ÀÏ¿øÀ¸·Î ¿©±â°í °íµµÀÇ °Ç°­ °ü¸®¸¦ ¿øÇÏ´Â °¡Á¤ÀÌ Áõ°¡ÇÔ¿¡ µû¶ó Àü ¼¼°èÀûÀ¸·Î ¹Ý·Áµ¿¹°À» ±â¸£´Â Àα¸°¡ Áõ°¡Çϰí ÀÖ´Ù´Â Á¡ÀÔ´Ï´Ù. ¹Ý·Áµ¿¹°ÀÇ Æò±Õ ¼ö¸íÀÌ ´Ã¾î³²¿¡ µû¶ó ¹Ý·Áµ¿¹°ÀÇ ¾Ï ¹ß»ý·üµµ Áõ°¡ÇÏ¿© Àü¹® Á¾¾çÇÐ ¼­ºñ½º¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. Áø´Ü, Ä¡·á, ¿ÏÈ­ Áö¿ø µîÀÇ Á¾ÇÕÀûÀÎ ¾Ï Ä¡·á¿¡ ÅõÀÚÇÏ·Á´Â ¹Ý·Áµ¿¹° º¸È£ÀÚµéÀÇ ÀÇÁö°¡ ¼öÀÇ Á¾¾çÇÐ ¼­ºñ½º¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

¾Ï Áõ»ó¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö°í ÷´Ü Áø´Ü µµ±¸ÀÇ °¡¿ë¼ºÀÌ ³ô¾ÆÁø °Íµµ ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¼öÀÇ»çµéÀÌ ¾ÏÀ» Á¶±â¿¡ ¹ß°ßÇÒ ¼ö ÀÖ°Ô µÊ¿¡ µû¶ó º¸´Ù È¿°úÀûÀÎ Ä¡·á °èȹ°ú ¿¹ÈÄ °³¼±ÀÌ °¡´ÉÇØÁ³½À´Ï´Ù. Á¾¾çÇÐ Àü¹® ¼­ºñ½º¸¦ Á¦°øÇÏ´Â µ¿¹°º´¿ø ¹× Ŭ¸®´Ð Áõ°¡¿Í µ¿¹°º´¿ø ÀÇ·Ú ¼¾ÅÍ Áõ°¡·Î ¹Ý·Áµ¿¹°ÀÇ ¾Ï Ä¡·á¿¡ ´ëÇÑ Á¢±Ù¼ºÀÌ Çâ»óµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¼öÀÇ Á¾¾çÇп¡¼­ ¿ø°ÝÀÇ·áÀÇ È°¿ëÀº Àü¹® Á¾¾ç Àü¹®ÀÇÀÇ È°µ¿ ¹üÀ§¸¦ ³ÐÇô ¿ø°Ý Áø·á, Ä¡·á °èȹ ¹× ÈÄ¼Ó Ä¡·á¸¦ °¡´ÉÇÏ°Ô ÇÏ¿© ÀÇ·á ¼­ºñ½º°¡ ºÎÁ·ÇÑ Áö¿ª¿¡¼­ Àü¹®Àû Ä¡·á¿¡ ´ëÇÑ Á¢±Ù¼ºÀ» Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù.

Ç¥ÀûÄ¡·á, Á¤¹ÐÀÇ·á, ÃÖ¼Òħ½À¼ö¼ú°ú °°Àº ±â¼úÀÇ ¹ßÀüÀº ¼öÀÇ Á¾¾çÇп¡¼­ »ç¿ëÇÒ ¼ö ÀÖ´Â Ä¡·á¹ýÀÇ ¼±ÅÃÀÇ ÆøÀ» Å©°Ô ³ÐÇô ¼º°ø·üÀ» ³ôÀÌ°í ºÎÀÛ¿ëÀ» ÁÙ¿´½À´Ï´Ù. ¼öÀÇÇÐ ¾Ï ¿¬±¸¿¡ ´ëÇÑ ±ÔÁ¦ ´ç±¹ÀÇ Áö¿ø°ú ÀÚ±Ý Áö¿øµµ ½Å¾à°ú Ä¡·á¹ý °³¹ß¿¡ ±â¿©Çϸç ÀÌ ºÐ¾ßÀÇ ±â¼ú Çõ½ÅÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. °íǰÁú µ¿¹° ÇコÄɾ ´ëÇÑ ¼ö¿ä°¡ Áö¼ÓÀûÀ¸·Î Áõ°¡ÇÏ´Â °¡¿îµ¥, ¹Ý·Áµ¿¹°ÀÇ °Ç°­ ÁõÁø, ¾Ï Ä¡·á¿¡ ´ëÇÑ ÀÎ½Ä °³¼±, ¾Ï ȯÀÚÀÇ °³º°Àû Ä¡·á¿¡ ´ëÇÑ °ü½É Áõ°¡ µî ¼¼°è Æ®·»µå¿¡ ÈûÀÔ¾î ¼öÀÇ Á¾¾çÇÐ ½ÃÀåÀº °ßÁ¶ÇÑ ¼ºÀåÀÌ ¿¹»óµÇ°í ÀÖ½À´Ï´Ù.

ºÎ¹®

Ä¡·á¹ý(È­Çпä¹ý, ¹æ»ç¼±¿ä¹ý, ¸é¿ª¿ä¹ý, ¼ö¼ú, ±âŸ Ä¡·á¹ý), ¾Ï À¯Çü(¸²ÇÁÁ¾, ºñ¸¸¼¼Æ÷¾Ï, À¯¹æ¾Ï, ÆíÆò»óÇǾÏ, ±âŸ ¾Ï À¯Çü), µ¿¹°ÀÇ À¯Çü(°³, °í¾çÀÌ)

Á¶»ç ´ë»ó ±â¾÷ ¿¹½Ã(ÃÑ 42°Ç)

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Veterinary Oncology Market to Reach US$727.8 Million by 2030

The global market for Veterinary Oncology estimated at US$358.2 Million in the year 2023, is expected to reach US$727.8 Million by 2030, growing at a CAGR of 10.7% over the analysis period 2023-2030. Chemotherapy, one of the segments analyzed in the report, is expected to record a 11.8% CAGR and reach US$246.0 Million by the end of the analysis period. Growth in the Radiology segment is estimated at 9.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$93.4 Million While China is Forecast to Grow at 14.0% CAGR

The Veterinary Oncology market in the U.S. is estimated at US$93.4 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$168.0 Million by the year 2030 trailing a CAGR of 14.0% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.2% and 8.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 8.3% CAGR.

Global Veterinary Oncology Market - Key Trends & Drivers Summarized

What Is Veterinary Oncology, and Why Is It So Crucial in Animal Healthcare?

Veterinary Oncology is a specialized field of veterinary medicine focused on diagnosing, treating, and managing cancer in animals. It encompasses various treatment modalities such as chemotherapy, radiation therapy, immunotherapy, surgery, and targeted therapy, designed to treat different types of cancers, including lymphomas, mast cell tumors, osteosarcomas, and melanomas in pets, livestock, and even exotic animals. Veterinary oncology aims to extend the lifespan of animals, alleviate pain, and improve the quality of life for cancer patients through early diagnosis, advanced treatment options, and ongoing care.

The importance of veterinary oncology lies in its ability to provide comprehensive cancer care for animals, addressing an increasing prevalence of cancer among companion animals such as dogs and cats, as well as livestock and wildlife. As pets are living longer due to improved healthcare, nutrition, and living conditions, age-related conditions like cancer have become more common. Veterinary oncology offers specialized diagnostic tools, personalized treatment plans, and palliative care, helping pet owners manage complex cancer cases more effectively. With growing awareness of animal welfare and the emotional bond between pet owners and their animals, veterinary oncology has become a vital component of modern veterinary medicine, aligning with broader trends toward more advanced and compassionate care for animals.

How Are Technological Advancements Shaping the Veterinary Oncology Market?

Technological advancements have significantly enhanced the diagnostic, therapeutic, and palliative capabilities of Veterinary Oncology, driving innovation across the field. One of the major developments is the rise of advanced diagnostic imaging technologies, such as computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET), and ultrasound. These imaging modalities provide detailed insights into tumor size, location, and progression, enabling veterinarians to accurately diagnose cancer, plan treatments, and monitor responses. Imaging-guided biopsies and surgeries have also improved precision, minimizing tissue damage and increasing the likelihood of successful tumor removal.

Advancements in targeted therapies and immunotherapies have transformed veterinary oncology, offering new options for treating cancers in animals. Targeted therapies use drugs designed to attack specific cancer cells without affecting healthy tissues, improving efficacy and reducing side effects. Tyrosine kinase inhibitors (TKIs) and monoclonal antibodies are examples of targeted treatments that are increasingly being used in veterinary oncology, especially for conditions like mast cell tumors and lymphomas. Immunotherapies, which stimulate the animal’s immune system to recognize and destroy cancer cells, are also emerging as promising treatments for various types of tumors in animals. Vaccines, such as the melanoma vaccine for dogs, represent a significant breakthrough in using immunotherapy to manage aggressive cancers.

The adoption of precision medicine, including genetic testing and molecular diagnostics, has enabled veterinarians to develop more personalized treatment plans. By analyzing the genetic makeup of tumors, veterinary oncologists can identify specific mutations that guide treatment decisions, increasing the effectiveness of therapies and improving survival rates. The integration of radiation therapy has also advanced, with the use of stereotactic radiation therapy (SRT) and intensity-modulated radiation therapy (IMRT), offering high-dose, targeted treatments that minimize damage to surrounding healthy tissues. These technological innovations not only expand the treatment options available in veterinary oncology but also align with broader trends toward more personalized, precise, and effective cancer care for animals.

What Are the Emerging Applications of Veterinary Oncology Across Different Animal Types?

Veterinary Oncology is finding expanding applications across a variety of animal species, driven by the need for specialized cancer care in both companion and non-companion animals. In companion animals, such as dogs and cats, oncology treatments are commonly used for lymphomas, mast cell tumors, osteosarcomas, and mammary gland tumors. Chemotherapy remains a widely used treatment option, often in combination with surgery or radiation therapy, depending on the type and stage of the cancer. The use of less invasive surgical techniques, such as laparoscopic tumor removal, has also increased in treating small animals, offering quicker recovery times and improved outcomes.

In large animals, including horses and livestock, veterinary oncology is applied to manage conditions such as squamous cell carcinoma, sarcoids, and lymphoma. While the treatment options may differ due to anatomical and physiological variations, advanced therapies like radiation and cryosurgery are employed to treat tumors in horses, improving survival rates and quality of life. Chemotherapy protocols tailored for large animals, combined with supportive care, are also part of veterinary oncology practice for managing certain types of cancers in livestock, particularly those affecting valuable breeding animals.

In exotic animals and wildlife, veterinary oncology has become essential for managing cancers in zoo animals, birds, reptiles, and other species under human care. These animals present unique challenges in cancer treatment due to differences in anatomy, behavior, and immune response, requiring specialized diagnostic and therapeutic approaches. For example, innovative approaches like electrochemotherapy (a combination of chemotherapy and electrical pulses) are used to treat tumors in small mammals and exotic pets, offering an effective and minimally invasive option. The expanding applications of veterinary oncology across diverse animal types underscore its critical role in advancing animal healthcare and improving outcomes for animals with cancer.

What Drives Growth in the Veterinary Oncology Market?

The growth in the Veterinary Oncology market is driven by several factors, including increasing pet ownership, rising awareness of pet health, and advancements in cancer treatment technologies. One of the primary growth drivers is the global rise in pet ownership, with more households viewing pets as family members and seeking advanced healthcare options for them. As the average lifespan of pets increases, the incidence of cancer among companion animals has also risen, creating greater demand for specialized oncology services. Pet owners’ willingness to invest in comprehensive cancer care, including diagnostics, treatment, and palliative support, has fueled the demand for veterinary oncology services.

The growing awareness of cancer symptoms and the availability of advanced diagnostic tools have also contributed to market growth. Veterinarians are now able to detect cancers earlier, allowing for more effective treatment plans and better prognoses. The increasing number of veterinary clinics and hospitals offering specialized oncology services, coupled with the rise of veterinary referral centers, has improved access to cancer care for pets. Additionally, the use of telemedicine in veterinary oncology has expanded the reach of expert oncologists, enabling remote consultations, treatment planning, and follow-up care, which enhances access to specialized treatments in underserved areas.

Technological advancements, including targeted therapies, precision medicine, and minimally invasive procedures, have significantly expanded the treatment options available in veterinary oncology, improving success rates and reducing side effects. Regulatory support and funding for veterinary cancer research have also contributed to the development of new drugs and treatments, driving innovation in the field. As the demand for high-quality animal healthcare continues to grow, the Veterinary Oncology market is poised for robust expansion, supported by global trends toward better pet health, increasing awareness of cancer treatments, and a growing focus on personalized care for animals with cancer.

SCOPE OF STUDY:

The report analyzes the Veterinary Oncology market in terms of US$ Thousand by the following Animal Type; Cancer Type; Therapy, and Geographic Regions/Countries:

Segments:

Therapy (Chemotherapy, Radiology, Immunotherapy, Surgery, Other Therapies); Cancer Type (Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer, Other Cancer Types); Animal Type (Canine, Feline)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â